Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 1:55 p.m.

    📋 Global Blood Therapeutics, Inc. (GBT) - Clinical Trial Update

    Filing Date: 2022-07-14

    Accepted: 2022-07-14 10:05:02

    Event Type: Clinical Trial Update

    Event Details:

    Global Blood Therapeutics Inc (the company became a subdivision of the company Pfizer Inc (PFE)) (GBT) Announces Clinical Trial Update Global Blood Therapeutics Inc (the company became a subdivision of the company Pfizer Inc (PFE)) (GBT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: authorized, patients
    • Diseases/Conditions: use in Brazil, Brazil who may benefit from voxelotor
    • Collaboration: ANVISA

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Global Blood Therapeutics Inc (the company became a subdivision of the company Pfizer Inc (PFE))
    • CIK: 0001629137
    • Ticker Symbol: GBT
    • Period End Date: 2022-07-14
    • Document Type: 8-K

Search

News categories